📝 Biossil raises $70M

Sponsored by

News of the Day

Toronto-based biotech startup Biossil has officially exited stealth mode, announcing it has raised approximately $70 million in equity to date. Boasting a high-profile cap table that includes OpenAI, Founders Fund, and Staircase Ventures, the company is valued in the "nine-figure" range. Led by former RBCx venture head Anthony Mouchantaf and Dr. Alexander Mosa, Biossil utilizes a proprietary AI platform to identify and "rescue" discarded drug molecules—candidates that showed promise but failed to reach the finish line in previous clinical trials. By licensing or purchasing these assets, Biossil bypasses the high-risk "starting from scratch" phase typical of traditional drug development.

If you have tweets you want to submit to be featured here (from you or someone you like), reply to this email with a link!

Chart of the Day